(KAIT/NBC) - More than 38 million Americans suffer from migraines.
The first-ever drug designed specifically for migraines hit the market earlier this summer.
The Food and Drug Administration in May approved the new medication, Aimovig, which targets a protein related to migraines called CGRP.
Dr. Allison Henderson tried more than 30 medicines but nothing eased the pain.
She turned out to be the perfect candidate for this new class of drug.
Dr. Priyanka Chaudhry says patients inject the medicine into their thigh or belly once a month.
It can take up to four weeks to work, while traditional treatments might take up to 12 weeks.
She says it also doesn't come with severe side effects associated with traditional treatments.
"What happens is when you release CGRP, the migraines can be can be more intense," Chaudhry said. "Here we have a drug which can actually block the mechanism of CGRP"
Allison went from three or more moderate to severe migraines each week to just one mild headache.
There is no cure for migraines, but Allison can now manage them unlike never before.
Three more drugmakers plan to release their version of the drug in the next two years.
Click here to find out more about Aimovig.